Showing results (131-140 of 690) with videos related to

Sort By:
Pageof 69
Cardiovascular Research|March 23, 2021
Human-induced pluripotent stem cells in cardiovascular research: current approaches in cardiac differentiation, maturation strategies, and scalable productionDilip Thomas, Nathan J Cunningham, Sushma Shenoy, et al.
Journal of Molecular and Cellular Cardiology|October 2, 2025
Decoding long COVID-associated cardiovascular dysfunction: Mechanisms, models, and new approach methodologiesDilip Thomas, Phillip C Yang, Joseph C Wu, et al.
Journal of Psychoactive Drugs|May 28, 2011
Reversing brain damage in former NFL players: implications for traumatic brain injury and substance abuse rehabilitationDaniel G Amen, Joseph C Wu, Derek Taylor, et al.
Frontiers in Pharmacology|April 1, 2021
Human Induced Pluripotent Stem Cells as a Screening Platform for Drug-Induced Vascular ToxicityChengyi Tu, Nathan J Cunningham, Mao Zhang, et al.
Circulation Research|April 5, 2021
Generation of Vascular Smooth Muscle Cells From Induced Pluripotent Stem Cells: Methods, Applications, and ConsiderationsMengcheng Shen, Thomas Quertermous, Michael P Fischbein, et al.
International Journal of Cardiology|August 11, 2007
Surgically palliated double-inlet left ventricle with transposition of the great arteries mistaken for aortic aneurysm with dissectionAnurag Gupta, Dominik Fleischmann, Daniel J Murphy, et al.
Advanced Drug Delivery Reviews|October 3, 2015
Engineered heart tissues and induced pluripotent stem cells: Macro- and microstructures for disease modeling, drug screening, and translational studiesEvangeline Tzatzalos, Oscar J Abilez, Praveen Shukla, et al.
Nature Communications|April 8, 2014
Phosphorylation of EXO1 by CDKs 1 and 2 regulates DNA end resection and repair pathway choiceNozomi Tomimatsu, Bipasha Mukherjee, Molly Catherine Hardebeck, et al.
Research Square|April 17, 2026
Engineered hematopoietic stem cells give rise to therapeutic antibody secreting B cellsMatthew Porteus, Sofia Luna, William Feist, et al.
Circulation. Heart Failure|September 1, 2012
Elevated levels of the mediator of catabolic bone remodeling RANKL in the bone marrow environment link chronic heart failure with osteoporosisDavid M Leistner, Florian H Seeger, Ariane Fischer, et al.
Pageof 69